Avigen to Present At UBS Global Life Sciences Conference
17 sept. 2008 11h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., Sept. 17, 2008 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company innovating therapeutics for neurological care, announced today that President and CEO Kenneth...
Avigen Hosts Research Day
03 sept. 2008 08h00 HE
|
Avigen, Inc.
Management and Key Opinion Leaders to Review Product Pipeline and
Development Strategy
Webcast Scheduled for 12:15 p.m. (ET) On Wednesday, September 10,
...
Avigen Reports Second Quarter 2008 Financial Results
30 juil. 2008 08h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., July 30, 2008 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company innovating therapeutics for neurological care, today reported financial results for its second...
Avigen's AV650 Patent Strategy Leads to Expanded Development Agreement
23 juil. 2008 08h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., July 23, 2008 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, today announced an amendment to the company's...
Avigen Reports First Quarter 2008 Financial Results and Discusses AV650 Patent Strategy
30 avr. 2008 08h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., April 30, 2008 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, today reported financial results for its...
Avigen to Present At Cowen & Company Health Care Conference
11 mars 2008 08h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., March 11, 2008 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, announced today that Chief Business Officer...
Avigen to Present At BIO CEO & Investor Conference
07 févr. 2008 08h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., Feb. 7, 2008 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, announced today that President and Chief...
Avigen Reports 2007 Financial Results and Reviews Clinical Progress
06 févr. 2008 08h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., Feb. 6, 2008 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, today reported financial results for its fourth...
Avigen to Present At Upcoming Healthcare Conferences
05 déc. 2007 08h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., Dec. 5, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company innovating therapeutics for neurological care, announced today that Avigen will present...
Avigen to Present At 2007 Credit Suisse Phoenix Health Care Conference
08 nov. 2007 18h06 HE
|
Avigen, Inc.
ALAMEDA, Calif., Nov. 8, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, announced today that Chief Business Officer...